| abstract |
3-(2-AMINOPYRIMIDIN-4-IL)-5-(3-HYDROXYPROPINYL)-1H-PYRROLO[2,3-C]PYRIDINE DERIVATIVES AS NIK INHIBITORS FOR THE TREATMENT OF CANCER. The present invention relates to compounds of formula (I) (I) which are inhibitors of NF-kB inducing kinase (NIK - also known as MAP3K14) useful for the treatment of diseases such as cancer, inflammatory disorders, metabolic disorders , and autoimmune disorders. The invention is also directed to pharmaceutical compositions comprising such compounds, to processes for preparing such compounds and compositions, and to the use of such compounds or pharmaceutical compositions for the prevention or treatment of diseases such as cancer, inflammatory disorders, metabolic disorders including obesity and diabetes. , and autoimmune disorders. |